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Low ﬂow valveAccepted treatment of patients with Idiopathic Normal Pressure Hydrocephalus (INPH) dictates the
placement of a Ventriculoperitoneal (VP) shunt. Selection of a valve regulated system for implantation is
usually determined by the treating surgeon. Data regarding the efﬁcacy of a Low Flow Valve (LFV) are sparse.
The use of this type of system may be of beneﬁt in patients with INPH. Data from fourteen patients in the
Florida Hospital NPH Program Registry with placement of a Low Flow Valve were retrospectively examined.
All patients completed baselines studies to quantify gait disturbance, cognitive dysfunction, and
ventriculomegaly (Evan's Ratio). Studies were repeated post three day external lumbar drain, as well as 6,
12, and 24 months post shunt placement. Signiﬁcant improvement was noted in gait (Berg Balance Score) at
six months and one year post shunt placement. Patients improved from a "medium" fall risk to a "low" fall
risk. Signiﬁcant improvement in NAB was noted at 2 years of follow up, improving from "mildly impaired" to
"average". Evan's ratio was stable throughout the study. There were no instances of over drainage or shunt
infection. One shunt obstruction which necessitated surgical intervention was observed. Objective
improvement in BERG and NAB appears to provide conclusive evidence of efﬁcacy in this small group of
patients with INPH treatedwith placement of an LFV and followed for two years. The absence of over-drainage
as a related complication in this small group is encouraging.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Accepted treatment of patients with Idiopathic Normal Pressure
Hydrocephalus (INPH) dictates the placement of a Ventriculoperitoneal
(VP) shunt. Selection of a valve regulated system for implantation is
usually determined by the treating surgeon. The use of a programmable
Differential Pressure valve system is currently a popular choice, however
problems related to over-drainage, MRI compatibility, and frequent
reprogramming are not uncommon with these systems. Data regarding
the efﬁcacy of a LowFlowValve (LFV) System in the treatment of patients
with Idiopathic Normal Pressure Hydrocephalus (INPH) are sparse. The
use of this type of system may be of beneﬁt in patients with INPH. This
paper provides evidence for the usefulness of the LFV System in the
treatment of patients with this disorder by examining pre-operative and
post-operative outcome data which address hallmark indicators of INPH
such as magnetic gait, cognitive dysfunction, and ventriculomegaly. This
study is a prelude to a larger randomized trial comparing its effectiveness
to a Differential Pressure valve system. (See Fig. 2.)ncial support was received
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Data from fourteen patients in the Florida Hospital NPH Program
Registry with placement of a Low Flow Valve were retrospectively
examined. Patient history was reviewed to exclude secondary causes
of hydrocephalus, and to include only those patients with suspected
INPH. All patients completed an MRI (CT if indicated), BERG Balance
Scale (BERG) and Neuropsychological Assessment Battery (NAB) at
baseline then 6 and 12 months postoperatively.
To quantify INPH hallmark gait disturbances such as gait apraxia,
hypokinesia, and disequilibrium [1] the BERG (BERG) Balance Scale
was utilized. The BERG Balance Scale is a standard reproducible
assessment which assigns a numeric value (1–56) to patients
performing balancing tasks inclusive of sitting to standing, standing
on one foot, standing with feet together, and standing/sitting
unsupported [2]. Though in published literature the Timed Up and
Go (TUG) test was administered to evaluate gait in patients with NPH
[3], the BERG by deﬁnition was designed to measure balance
speciﬁcally among older individuals for quantitative descriptions of
function and fall risk in clinical practice and research.
The principle cognitive symptoms seen in INPH are suggestive of a
subcortical dementing process, including slowing of thought, inat-
tentiveness, apathy, encoding and recall problems, as well as impaired
executive functions [3,4]. When possible, quantiﬁable measures of
cognitive performance (neuropsychological tests) should be used [4].er the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Fig. 1. NAB scores associated with improvement at baseline (Day 1), post ELD (Day 3),
as well as 6, 12, and 24 months post operatively.
Table 1
Patient co-morbidities in 14 patients treated with a Low Flow Valve.
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inant cognitive measuring tool in this study. The NAB is a
comprehensive, modular battery of Neuropsychological tests devel-
oped for the assessment of a wide variety of cognitive skills and
functions in adults aged 18–97 with known or suspected disorders of
the central nervous system [5]. The modules test attention, language,
memory, spatial, and executive scores to generate a numerical Total
Screening Index.
Brain Magnetic Resonance Imaging (3 T MRI) was utilized to
identify ventriculomegaly. The Evan’s Ratio, which is deﬁned as the
maximal width of the frontal horns measured at their extreme to the
maximal biparietal diameter was documented. CSF ﬂow studies
through the Aqueduct of Sylvius such as Stroke Volume and Stroke
Velocity were additionally documented components, these ﬁndings
will be discussed in a future publication.
Upon admission to the Florida Hospital NPH Program, the three
evaluations (BERG, NAB, and MRI) were completed at baseline upon
hospital entry. A Lumbar Sub-Arachnoid drain was then inserted and
CSF was drained (10 ml/h) over 48–72 h. Repeat testing (BERG, NAB,
MRI) was then completed and the lumbar drain was removed before
the patient was discharged on Day 3. Baseline testing was compared
to Day 3 Data, and a likelihood of beneﬁt was assigned subsequent to a
round table discussion comprised of the specialists who treated the
patients. Repeat testing (BERG, NAB, and MRI) was completed 6, 12,
and 24 months post shunt placement. Patients were also clinically
evaluated with CT scans between testing intervals to address over
drainage or other shunt related complications.
A Flow Regulating Ventriculoperitoneal shunt (Integra NPH Low
Flow Valve System™) was placed in all patients. These FlowFig. 2. BERG Balance Scores associated with improvement at baseline (Day 1), post ELD
(Day 3), as well as 6, 12, and 24 months post operatively.Regulating valves use variable resistance to the ﬂow of CSF at the
physiological rate of CSF production. This device does not have various
valve settings, and is designed to minimize potential postural and
vasogenic overdrainage situations. The Integra NPH Low Flow Valve
System™ ﬂow rate is 8–17 ml/h. All shunt procedures were done by
one surgeon (PSL), utilizing the same surgical team.
Nine patients were retested (BERG, NAB, MRI) at six months and
eight patients [were retested] (BERG, NAB, MRI) at twelve months post
shuntplacement. Six patientswere lost to followup. Sevenpatientswere
retested (BERG,NAB,MRI) at twenty-fourmonths post shunt placement,
and serve as the basis of this paper. One patient was excluded from two
year data due to shunt malfunction one year post operatively and
subsequent crossover to a Differential Pressure valve system.
Results
Of the 14 patients who had initial baseline evaluation (BERG, NAB,
MRI) and placement of the LFV, there were 7 women and 7men. Their
ages ranged from 63 to 87 years (mean 77.7 years). Co-morbidities
are listed in Table 1, and were as expected in this patient population.
In this group of patients with placement of the LFV, there were no
instances of shunt infection or over drainage during the period of this
study. Five patients were lost to follow up and one patient withdrew
due to an ischemic stroke. One patient developed recurrence of
symptoms after his one year evaluation and was returned to surgery
at which time the valve was found to be obstructed. This patient was
crossed over to a Differential Pressure valve and removed from further
data collection. There was no instance of over drainage. All follow ups
were routine and additional monitoring was not necessary.
Initial baseline testing in 14 patients revealedmean scores of BERG:
17.3 and NAB: 77.5. Day three of testing in 14 patients subsequent to
lumbar drain placement and prior to shunt placement was BERG: 21.3
andNAB: 79.9. Sixmonth data in 9 patients post shunt placementwere
BERG: 34.4 (99% improvement) and NAB: 79.6 (2.70% improvement).
One year data in 8 patients were BERG: 38.5 (122% improvement) and
NAB: 88.3 (13.93% improvement). Two year data in 7 patients were
BERG: 39.4 (127% improvement) and NAB: 93 (20% improvement).
Discussion
The data from this retrospective study of 14 patients indicate that a
ﬂow regulated valve system may signiﬁcantly improve the outcome
in INPH.
Gait
A BERG Balance Score change of 4 points is needed to be 95%
conﬁdent that true change has occurred if patients score within 45–56
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within 25–34 and, ﬁnally, 5 points if their initial score is within 0–24
on the Berg Balance Scale [5]. The changes noted in average patient
BERG score (22.1) in this study from Day 1 to 2 years testing
conclusively demonstrate (95% conﬁdence) that true change and
marked improvement in gait and balance occurred. Additionally,
these patients improved from a high fall risk to a medium fall
risk status.
Imaging
On MRI, the average Evan’s Ratio was essentially unchanged
throughout the study, recorded as 0.34 on Day 1 and 0.34 at 2 years of
follow up. This indicated an unchanged size ratio of the maximal
ventricular width divided by the maximumwidth of the inner table of
the cranium. In this study, the Evan’s Ratio was recorded by selected
neuro-radiologists, again suggesting satisfactory congruity.
The MRI posed no potential threat for valve related complications
or disturbances in these patients and did not require additional
clinical investigation for any instance of neuro deterioration.
Cognitive
The Average Total Screening Index of the NAB indicated a 15.5
point improvement in patient scores from 77.5 on Day 1 to 93 at
2 years of follow up. These scores demonstrate improvement from a
“mildly impaired” interpretive category to “average” [6]. The standard
deviation for improvement is approximately 15 points [7].
The one patient who required a shunt revision noted a gradual
decline in cognitive function shortly after her improved 1 year
evaluation. Unable to now stand or ambulate unassisted, her
incontinence had also returned. X-Ray Shunt Series was unremark-
able. The patient was then taken to surgerywhere the valvewas found
to be obstructed. A different valve system was placed.
The lack of any other post-operative complications such as over
drainage or subdural effusion suggests efﬁciency of this ﬂow
regulated valve system in patients with INPH. The exceptional
outcome in this small group of patients speculates paralleled successin a larger group of patients. Data for a larger, prospective comparative
study are currently being reviewed.
Conclusion
Objective improvement in BERG and NAB appears to provide
conclusive evidence of efﬁcacy in this small group of patients with
INPH treated with placement of an LFV and followed for two years.
The absence of over-drainage as a related complication in this small
group is encouraging. Documentation of progressive improvement
and stability in objectivemeasurements (BERG andNAB) is important.
The ease of use and limited follow up post operatively are desirable
and may compare favorably to the management necessary for
maintenance of a differential pressure valve system. A larger
prospective randomized study is under way to fully delineate salient
differences in the efﬁcacy of a Differential Pressure or Flow Regulated
Valvular device in the treatment of INPH.
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